High Intensity and Moderate Training and Maximal Oxygen Uptake and Activity Levels

Ageing Clinical Trial

Official title:

Effect of High Intensity and Moderate Training on Maximal Oxygen Uptake and Activity Levels in an Elderly Norwegian Population

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01931124
• Other study ID #: gen100sub4
• Status: Completed
• Phase: N/A
• Start date: August 2012
• Est. completion date: June 1, 2018

Study information

• Verified date: September 2018
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Aim of the study is to investigate the effect of different types of training (high intensity and moderate training) on maximal oxygen uptake and activity levels in an elderly Norwegian population after one year training intervention. Baseline data include the activity levels assessed through self reported means as well as objectively measured activity data using activity monitors.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1576
• Est. completion date: June 1, 2018
• Est. primary completion date: June 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 70 Years to 77 Years

Eligibility

Inclusion Criteria:

• ability to walk at least 1km,

• born in 1938,1939,1940,1941 or 1942

• Sufficiently good health to be able to take part in the study, as determined by the researchers

Exclusion Criteria:

• Illness or disability that precludes exercise or hinders completion of the study

• Uncontrolled hypertension

• Symptomatic valve disease, hyper tropic cardio-myopathy or unstable angina

• Active cancer

• Test results indicating that study participation is unsafe

• Inclusion in other studies conflicting with participation in this one

Related Conditions & MeSH terms

• Ageing

Intervention

Behavioral:
• High Intensity Training

• Moderate Intensity Training

Locations

Country	Name	City	State
Norway	Norwegian University of Science and Technology	Trondheim

Sponsors (1)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	maximal oxygen uptake		1 year
Primary	activity level		1 year